Though Vivus (VVUS) is still halted following the FDA's approval of Qnexa, Arena Pharmaceuticals...

|By:, SA News Editor

Though Vivus (VVUS) is still halted following the FDA's approval of Qnexa, Arena Pharmaceuticals (ARNA) is up 11.6% AH, and Orexigen Therapeutics (OREX) is up 14.3%. Arena and Orexigen have weight-loss drugs of their own (I, II) that are awaiting FDA approval.